Pfizer news
Pfizer to sell generic drugs in Japan - Nikkei
Pfizer to sell generic drugs in Japan - Nikkei
Reuters - 7 minutes ago
TOKYO, Nov 19 (Reuters) - Pfizer Inc (PFE.N), the world's largest drugmaker, plans to begin selling generic drugs in Japan as early as 2011, the Nikkei business daily reported on Thursday. The US ...
FDA panel recommends Pfizer's Prevnar
FDA panel recommends Pfizer's Prevnar
Philadelphia Inquirer - 6 minutes ago
A panel of federal health experts today voted in favor of an updated version of Pfizer Inc.'s best-selling anti-infection vaccine for infants and toddlers. The full Food and Drug Administration ...
MDVN Starts New Alzheimer's Trials
MDVN Starts New Alzheimer's Trials
Zacks.com - 1 hour ago
Earlier this month, Medivation, Inc. (MDVN - Analyst Report) and Pfizer, Inc. (PFE - Analyst Report) initiated two phase III studies, CONTACT and CONSTELLATION, with Dimebon in patients with ...
Another Study Questions Utility Of Merck Cholesterol Drugs
Another Study Questions Utility Of Merck Cholesterol Drugs
Wall Street Journal - 58 minutes ago
By Peter Loftus Of DOW JONES NEWSWIRES A new study by health insurer UnitedHealth Group Inc. (UNH) concludes Merck & Co.'s (MRK) cholesterol drug Vytorin didn't significantly reduce the risk of ...
Vivus reports postive study results for ED drug
Vivus reports postive study results for ED drug
MarketWatch - 30 minutes ago
BOSTON (MarketWatch) -- Vivus Inc. (NASDAQ:VVUS) early Wednesday reported positive Phase III clinical results for its new drug avanafil for the treatment of erectile dysfunction, or ED. "These ...
Pfizer (PFE) Trading Strategies With Downside Protection
Pfizer (PFE) Trading Strategies With Downside Protection
Market Intelligence Center - 37 minutes ago
Pfizer (NYSE: PFE) closed yesterday at $17.94. So far the stock has hit a 52-week low of $11.62 and 52-week high of $18.48. Pfizer stock has been showing support around 17.65 and resistance in the ...
